Weave at DIA Global Annual Meeting — Booth 1218
Don’t miss our talks:
Session Title:
The connected submission: How AI, automation, and intelligence are changing the regulatory ecosystem
Monday, June 15 | 1:05 – 1:35 PM | Innovation Theater 1
Session Description:
Regulatory teams are being asked to move faster while maintaining consistency and quality across increasingly complex submissions. Disconnected authoring processes and inconsistent standards make this difficult to scale.
Learn how AI-enabled authoring, process standardization, and automation can help teams accelerate submissions, improve consistency, and unlock new opportunities for regulatory intelligence and planning.
We’ll also share practical frameworks for implementing these capabilities within existing processes—what to change, what to keep, and how to approach adoption across teams.
Speakers:
Brandon Rice, CEO and Co-founder, Weave Bio
Katie Connelly, SVP, Global Head of Regulatory Affairs, Parexel
Tuesday, June 16 | 9:15 – 9:45 AM | Innovation Theater 3
Session Title:
Threading AI Throughout the Drug Development Lifecycle: An Enterprise Lens
Session Description:
Enterprise pharma teams face increasing pressure to move faster while maintaining the quality and consistency required for complex health authority interactions. Fragmented workflows and evolving data make this especially challenging at scale.
Learn how a unified, human-driven AI approach can help teams develop narratives more efficiently and consistently across the product lifecycle. We’ll share real-world lessons on selecting, implementing, and integrating AI within existing workflows.
Speakers:
Brandon Rice, CEO and Co-founder, Weave Bio
Andrew S. Robertson, Ph.D., JD, Vice President and Head of Global Regulatory Policy & Innovation, Takeda
